These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 24039596)

  • 1. Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition.
    Westra ER; Semenova E; Datsenko KA; Jackson RN; Wiedenheft B; Severinov K; Brouns SJ
    PLoS Genet; 2013; 9(9):e1003742. PubMed ID: 24039596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli.
    Hayes RP; Xiao Y; Ding F; van Erp PB; Rajashankar K; Bailey S; Wiedenheft B; Ke A
    Nature; 2016 Feb; 530(7591):499-503. PubMed ID: 26863189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.
    Wang L; Mo CY; Wasserman MR; Rostøl JT; Marraffini LA; Liu S
    Mol Cell; 2019 Jan; 73(2):278-290.e4. PubMed ID: 30503774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems.
    Meeske AJ; Marraffini LA
    Mol Cell; 2018 Sep; 71(5):791-801.e3. PubMed ID: 30122537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Characterization of Cascade type I-E CRISPR Guide Efficacy Reveals Unexpected PAM Diversity and Target Sequence Preferences.
    Fu BX; Wainberg M; Kundaje A; Fire AZ
    Genetics; 2017 Aug; 206(4):1727-1738. PubMed ID: 28634160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
    Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
    Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self versus non-self discrimination during CRISPR RNA-directed immunity.
    Marraffini LA; Sontheimer EJ
    Nature; 2010 Jan; 463(7280):568-71. PubMed ID: 20072129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloarcula hispanica CRISPR authenticates PAM of a target sequence to prime discriminative adaptation.
    Li M; Wang R; Xiang H
    Nucleic Acids Res; 2014 Jun; 42(11):7226-35. PubMed ID: 24803673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-spacer integration reporter plasmids reveal distinct genuine acquisition specificities among CRISPR-Cas I-E variants of Escherichia coli.
    Díez-Villaseñor C; Guzmán NM; Almendros C; García-Martínez J; Mojica FJ
    RNA Biol; 2013 May; 10(5):792-802. PubMed ID: 23445770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential requirements for the detection and degradation of invaders by the Haloferax volcanii CRISPR/Cas system I-B.
    Maier LK; Lange SJ; Stoll B; Haas KA; Fischer S; Fischer E; Duchardt-Ferner E; Wöhnert J; Backofen R; Marchfelder A
    RNA Biol; 2013 May; 10(5):865-74. PubMed ID: 23594992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing and integration of functionally oriented prespacers in the
    Ramachandran A; Summerville L; Learn BA; DeBell L; Bailey S
    J Biol Chem; 2020 Mar; 295(11):3403-3414. PubMed ID: 31914418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation
    Cooper LA; Stringer AM; Wade JT
    mBio; 2018 Apr; 9(2):. PubMed ID: 29666291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoidance of Trinucleotide Corresponding to Consensus Protospacer Adjacent Motif Controls the Efficiency of Prespacer Selection during Primed Adaptation.
    Musharova O; Vyhovskyi D; Medvedeva S; Guzina J; Zhitnyuk Y; Djordjevic M; Severinov K; Savitskaya E
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPRTarget: bioinformatic prediction and analysis of crRNA targets.
    Biswas A; Gagnon JN; Brouns SJ; Fineran PC; Brown CM
    RNA Biol; 2013 May; 10(5):817-27. PubMed ID: 23492433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
    Heler R; Samai P; Modell JW; Weiner C; Goldberg GW; Bikard D; Marraffini LA
    Nature; 2015 Mar; 519(7542):199-202. PubMed ID: 25707807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
    Takeshita D; Sato M; Inanaga H; Numata T
    J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering, Communicating, and Engineering the CRISPR PAM.
    Leenay RT; Beisel CL
    J Mol Biol; 2017 Jan; 429(2):177-191. PubMed ID: 27916599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degenerate target sites mediate rapid primed CRISPR adaptation.
    Fineran PC; Gerritzen MJ; Suárez-Diez M; Künne T; Boekhorst J; van Hijum SA; Staals RH; Brouns SJ
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1629-38. PubMed ID: 24711427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type III CRISPR-Cas Immunity: Major Differences Brushed Aside.
    Tamulaitis G; Venclovas Č; Siksnys V
    Trends Microbiol; 2017 Jan; 25(1):49-61. PubMed ID: 27773522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target motifs affecting natural immunity by a constitutive CRISPR-Cas system in Escherichia coli.
    Almendros C; Guzmán NM; Díez-Villaseñor C; García-Martínez J; Mojica FJ
    PLoS One; 2012; 7(11):e50797. PubMed ID: 23189210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.